Accuray says Asian business is booming:
This article was originally published in Clinica
Accuray, which develops and manufactures the CyberKnife stereotactic radiosurgery system, says that demand for its products in Asia is "soaring". Over the past year, the Sunnyvale, California company has received multiple orders valued at over $42 million. "Our Asia business has been core-building from a strategic standpoint and comprises an important part of our company," said Spencer Clawson, Accuray's CFO. The device combines robotic delivery of high doses of radiation with image-guidance technology to ablate solid tumours.
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.